Skip to search formSkip to main contentSkip to account menu

Plasminogen activator inhibitor Ag:MCnc:Pt:PPP:Qn:IA

Known as: Inhibidor del activador del Plasminogeno Ag:Concentración de masa:Punto temporal:Plasma pobre en plaquetas:Qn:IA, Plasminogeen activator remmer Ag:Massa concentratie:Moment:Plaatjesarm plasma:Kwantitatief:IA, ??????????? ????????? ????????? ??:????????:??????:???:?????:IA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Purpose A real-time intra-operative imaging modality is required to update the navigation systems during neurosurgery, since… 
2017
2017
Abstract Objective: Few studies have evaluated the symptom validity tests (SVTs) within the Personality Assessment Inventory (PAI… 
2015
2015
Increasing antibiotic resistance has compelled the development of novel antibiotics and adjuvant therapies that enhance the… 
2011
2011
OBJECTIVES Cone beam CT (CBCT) produces undistorted three-dimensional (3D) images of the maxillofacial region with a radiation… 
2008
2008
The 2009 Mars science laboratory mission is being designed to place an 850 kg rover on the surface of Mars at an altitude of at… 
2008
2008
In uropathogenic Escherichia coli strain 536, six pathogenicity islands (PAIs) encode key virulence factors. All PAIs except PAI… 
2007
2007
PAI-749 is a potent and selective synthetic antagonist of plasminogen activator inhibitor 1 (PAI-1) that preserved tissue-type… 
Highly Cited
2004
Highly Cited
2004
2004
2004
Rather long ago, Newell (1973) wrote a prophetic paper that could serve as a rallying cry for this 2004 symposium: “You Can’t… 
2001
2001
Pathogenicity islands (PAIs) represent distinct pieces of DNA that are present in the genomes of pathogenic bacteria but absent…